Reiter, A., Luebke, J., Gotlib, J., Álvarez-Twose, I., Radia, D., Bobbili, P., Wang, A., Dimitrijević, S., Ponet, O., Sullivan, E., Schwaab, J., Galinsky, I., Perkins, C., Sperr, W., Sriskandarajah, P., Mohan, M., Zhu, A., Duh, M. S., Valent, P., Deangelo, D., Rossignol, J., Hermine, O. (2025). Improved overall survival in patients with advanced systemic mastocytosis treated with avapritinib versus real-world therapy based on mutation-adjusted risk score (MARS) stratification. Blood. https://doi.org/10.1182/blood-2025-5595